Antimicrobial Resistance and Spread of Multi Drug Resistant Escherichia coli Isolates Collected from Nine Urology Services in the Euregion Meuse-Rhine

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  van der Donk, Christina F M ^a,b   van de Bovenkamp, Jeroen H B ^c   de Brauwer, Els I G B ^d   de Mol, Patrick ^e   Feldhoff, Karl Heinz ^f   Kalka Moll, Wiltrud M ^g   Nys, Sita ^h   Thoelen, Inge ⁱ   Trienekens, Thera A M ^j   Stobberingh, Ellen E ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c Stichting Laboratoria voor Pathologie en Medische Microbiologie   (Netherlands)

^d Sittard Geleen Heerlen   (Netherlands)

^e UNIVERSITY OF LIÈGE   (Belgium)

^f Gesundheitsamt des Kreises Heinsberg   (Germany)

^g Medical Care Centre Dr Stein and Colleagues   (Germany)

^h JESSA HOSPITAL   (Belgium)

ⁱ General Hospital Vesalius   (Belgium)

^j VIECURI MEDICAL CENTER   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE CTX M; BETA LACTAMASE TEM 1; CARBAPENEM; CEFEPIME; CEFIXIME; CEFOTAXIME; CEFTAZIDIME; CEFTIBUTEN; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; FOLIC ACID ANTAGONIST; GENTAMICIN; LEVOFLOXACIN; MOXIFLOXACIN; NITROFURANTOIN; NORFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATION; BELGIUM; CONTROLLED STUDY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GERMANY; HUMAN; MULTIDRUG RESISTANCE; NETHERLANDS; NONHUMAN; URINARY TRACT INFECTION;

ANTI-INFECTIVE AGENTS; BACTERIAL TYPING TECHNIQUES; BELGIUM; BETA-LACTAMASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GERMANY; HUMANS; MICROBIAL SENSITIVITY TESTS; NETHERLANDS; SPECIMEN HANDLING; UROLOGY;

EID: 84867630001     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047707     Document Type: Article

References (34)

1. ECDC (2010) Antimicrobial resistance surveillance in Europe 2009. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC.
2. den Heijer CD, Donker GA, Maes J, Stobberingh EE, (2010) Antibiotic susceptibility of unselected uropathogenic Escherichia coli from female Dutch general practice patients: a comparison of two surveys with a 5 year interval. J Antimicrob Chemother 65: 2128-2133.
3. Cullen IM, Manecksha RP, McCullagh E, Ahmad S, O'Kelly F, et al. (2011) The changing pattern of antimicrobial resistance within 42 033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999-2009. BJU Int.
4. SWAB (2011) Nethmap 2011- Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands.
5. Goossens H, Ferech M, Vander Stichele R, Elseviers M, (2005) Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365: 579-587.
6. Gibreel TM, Dodgson AR, Cheesbrough J, Fox AJ, Bolton FJ, et al. (2012) Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England. J Antimicrob Chemother 67: 346-356.
7. Pitout JD, Gregson DB, Campbell L, Laupland KB, (2009) Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections. Antimicrob Agents Chemother 53: 2846-2851.
8. Nys S, Terporten PH, Hoogkamp-Korstanje JA, Stobberingh EE, (2008) Trends in antimicrobial susceptibility of Escherichia coli isolates from urology services in The Netherlands (1998-2005). J Antimicrob Chemother 62: 126-132.
9. Naber KG, Schito G, Botto H, Palou J, Mazzei T, (2008) Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. Eur Urol 54: 1164-1175.
10. EIS (2006) Euregion Meuse-Rhine in figures.
11. EUCAST Breakpoint tables for interpretation of MICs and zone diameters- version 1.3, January 2011.
12. NVMM (2008) NVMM Richtlijn voor screening en confirmatie van extended-spectrum beta-lactamases (ESBL's) in Enterobacteriaceae.
13. Pallecchi L, Malossi M, Mantella A, Gotuzzo E, Trigoso C, et al. (2004) Detection of CTX-M-type beta-lactamase genes in fecal Escherichia coli isolates from healthy children in Bolivia and Peru. Antimicrob Agents Chemother 48: 4556-4561.
14. Saladin M, Cao VT, Lambert T, Donay JL, Herrmann JL, et al. (2002) Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol Lett 209: 161-168.
15. Ribot EM, Fair MA, Gautom R, Cameron DN, Hunter SB, et al. (2006) Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis 3: 59-67.
16. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, et al. (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33: 2233-2239.
17. UCC Escherichia coli MLST database http://mlst.ucc.ie/mlst/dbs/Ecoli (6 July 2012- date last accessed).
18. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, et al. (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52: e103-120.
19. Narum SR, (2006) Beyond Bonferroni: Less conservative analyses for conservation genetics. Conservation Genetics 7: 783-787.
20. SWAB Antibioticaboekje. http://customid.duhs.duke.edu/NL/Main/Start.asp (date last accesed: 1 November 2011).
21. Overdevest I, Willemsen I, Rijnsburger M, Eustace A, Xu L, et al. (2011) Extended-spectrum beta-lactamase genes of Escherichia coli in chicken meat and humans, The Netherlands. Emerg Infect Dis 17: 1216-1222.
22. Rodriguez-Villalobos H, Bogaerts P, Berhin C, Bauraing C, Deplano A, et al. (2011) Trends in production of extended-spectrum beta-lactamases among Enterobacteriaceae of clinical interest: results of a nationwide survey in Belgian hospitals. J Antimicrob Chemother 66: 37-47.
23. Wagenlehner FM, Niemetz AH, Weidner W, Naber KG, (2008) Spectrum and antibiotic resistance of uropathogens from hospitalised patients with urinary tract infections: 1994-2005. Int J Antimicrob Agents 31 (Suppl 1):: S25-34.
24. ESAC European Surveillanc of Antimicrobial Consumption Yearbook 2009.
25. De Backer D, Christiaens T, Heytens S, De Sutter A, Stobberingh EE, et al. (2008) Evolution of bacterial susceptibility pattern of Escherichia coli in uncomplicated urinary tract infections in a country with high antibiotic consumption: a comparison of two surveys with a 10 year interval. J Antimicrob Chemother 62: 364-368.
26. Yagupsky P, (2006) Selection of antibiotic-resistant pathogens in the community. Pediatr Infect Dis J 25: 974-976.
27. Colodner R, Kometiani I, Chazan B, Raz R, (2008) Risk factors for community-acquired urinary tract infection due to quinolone-resistant E. coli. Infection 36: 41-45.
28. Charalabopoulos K, Karachalios G, Baltogiannis D, Charalabopoulos A, Giannakopoulos X, et al. (2003) Penetration of antimicrobial agents into the prostate. Chemotherapy 49: 269-279.
29. Coque TM, Baquero F, Canton R (2008) Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill 13.
30. van der Donk CF, Beisser PS, Hoogkamp-Korstanje JA, Bruggeman CA, Stobberingh EE, (2011) A 12 year (1998-2009) antibiotic resistance surveillance of Klebsiella pneumoniae collected from intensive care and urology patients in 14 Dutch hospitals. J Antimicrob Chemother 66: 855-858.
31. Jans B, Glupczynski Y (2009) Surveillance van multiresistente kiemen in Belgische ziekenhuizen: Enterobacter aerogenens en cloacae, Escherichia coli, Klebsielle pneumoniae, Acinetobacter baumanii en Pseudomonas aeruginosa Eerste semester. Brussel: Wetenschappelijk Instituut Volksgezondheid.
32. SWAB (2006) Richtlijn antimicrobiële therapie bij gecompliceerde urineweginfecties.
33. Lee SS, Kim Y, Chung DR, (2011) Impact of discordant empirical therapy on outcome of community-acquired bacteremic acute pyelonephritis. J Infect 62: 159-164.
34. Raz R, (2012) Fosfomycin: an old-new antibiotic. Clin Microbiol Infect 18: 4-7.